$60.8 Billion is the total value of Baillie Gifford's 547 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VVR | Invesco Senior Income Trust | $41,524,000 | +7.2% | 8,949,118 | 0.0% | 0.07% | +11.5% | |
| PPR | Voya Prime Rate Trustsh ben int | $40,413,000 | +4.9% | 7,294,676 | 0.0% | 0.07% | +10.0% | |
| TREE | Lendingtree | $22,875,000 | +4.6% | 225,700 | 0.0% | 0.04% | +11.8% | |
| RAI | Reynolds American | $21,218,000 | +18.9% | 378,626 | 0.0% | 0.04% | +25.0% | |
| BGT | BlackRock Floating Rate Income | $16,192,000 | +4.1% | 1,150,000 | 0.0% | 0.03% | +12.5% | |
| VECO | Veeco Instruments | $16,109,000 | +48.5% | 552,644 | 0.0% | 0.03% | +52.9% | |
| PHD | Pioneer Floating Rate Trust | $14,681,000 | +0.6% | 1,236,803 | 0.0% | 0.02% | +4.3% | |
| NSL | Nuveen Senior Income Fund | $13,003,000 | +3.8% | 1,915,000 | 0.0% | 0.02% | +5.0% | |
| EVF | Eaton Vance Senior Income Trustsh ben int | $12,592,000 | +3.7% | 1,885,000 | 0.0% | 0.02% | +10.5% | |
| BCRHF | Blue Capital Reinsurance Holdings Fund (USD) | $11,613,000 | +0.7% | 629,438 | 0.0% | 0.02% | +5.6% | |
| AFT | Apollo Senior Floating Rate | $10,749,000 | +2.7% | 617,746 | 0.0% | 0.02% | +12.5% | |
| SLB | Schlumberger | $10,001,000 | +6.8% | 119,127 | 0.0% | 0.02% | +6.7% | |
| CSLT | Castlight Health Inccl b | $8,884,000 | +19.0% | 1,794,820 | 0.0% | 0.02% | +25.0% | |
| VAR | Varian Medical Systems Inc | $9,038,000 | -9.8% | 100,667 | 0.0% | 0.02% | -6.2% | |
| EL | Estee Lauder 'A' | $8,535,000 | -13.6% | 111,584 | 0.0% | 0.01% | -6.7% | |
| PX | Praxair | $8,229,000 | -3.0% | 70,221 | 0.0% | 0.01% | +7.7% | |
| AVAV | Aerovironment | $7,719,000 | +9.9% | 287,710 | 0.0% | 0.01% | +18.2% | |
| LTRPA | Liberty Tripadvisor Holding A | $8,177,000 | -31.1% | 543,314 | 0.0% | 0.01% | -31.6% | |
| PCRX | Pacira Pharmaceuticals | $6,899,000 | -5.6% | 213,600 | 0.0% | 0.01% | 0.0% | |
| EXA | Exa Corp | $6,445,000 | -4.3% | 419,630 | 0.0% | 0.01% | 0.0% | |
| FARO | Faro Technologies | $6,267,000 | +0.1% | 174,080 | 0.0% | 0.01% | 0.0% | |
| POWI | Power Integrations | $5,474,000 | +7.6% | 80,680 | 0.0% | 0.01% | +12.5% | |
| MCHP | Microchip Technology | $5,303,000 | +3.3% | 82,660 | 0.0% | 0.01% | +12.5% | |
| LXFT | Luxoft Holding | $5,447,000 | +6.3% | 96,930 | 0.0% | 0.01% | +12.5% | |
| EPAM | EPAM Systems | $5,459,000 | -7.2% | 84,900 | 0.0% | 0.01% | 0.0% | |
| DMRC | Digimarc | $5,235,000 | -21.8% | 174,500 | 0.0% | 0.01% | -10.0% | |
| CDXS | Codexis | $5,451,000 | +3.6% | 1,185,133 | 0.0% | 0.01% | +12.5% | |
| NVDQ | Novadaq Technologies Inc | $4,995,000 | -38.7% | 704,480 | 0.0% | 0.01% | -38.5% | |
| ADAP | Adaptimmune Therapeutics ADRsponds adr | $3,730,000 | -42.6% | 920,984 | 0.0% | 0.01% | -40.0% | |
| FMI | Foundation Medicine | $3,094,000 | -24.2% | 174,800 | 0.0% | 0.01% | -16.7% | |
| BIOAQ | Bioamber | $3,188,000 | +29.8% | 579,540 | 0.0% | 0.01% | +25.0% | |
| ADRO | Aduro Biotechnology | $3,306,000 | -8.3% | 290,000 | 0.0% | 0.01% | -16.7% | |
| WB | Weibo Corp SPON ADRsponsored adr | $2,484,000 | -19.0% | 61,182 | 0.0% | 0.00% | -20.0% | |
| RIO | Rio Tinto Spn.Adr 1:1sponsored adr | $2,716,000 | +15.1% | 70,626 | 0.0% | 0.00% | 0.0% | |
| ACTG | Acacia Reasearch Corp | $2,378,000 | -0.3% | 365,820 | 0.0% | 0.00% | 0.0% | |
| FOMX | Foamix Pharmaceuticals | $2,435,000 | +19.8% | 219,400 | 0.0% | 0.00% | +33.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Amazon.Com | 42 | Q3 2023 | 10.0% |
| Tesla Motors | 42 | Q3 2023 | 10.7% |
| Illumina | 42 | Q3 2023 | 6.6% |
| Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
| Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
| MercadoLibre | 42 | Q3 2023 | 7.3% |
| Intuitive Surgical | 42 | Q3 2023 | 3.5% |
| Moody's Corp | 42 | Q3 2023 | 1.4% |
| MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
| Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
| Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
| SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
| UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
| CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
| MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
| Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
| CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
| EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
| CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-01 |
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-03-07 |
| SC 13G/A | 2024-03-06 |
| SC 13G/A | 2024-02-07 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-30 |
| SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.